We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT03003637
Brief Title: ImmunoModulation by the Combination of Ipilimumab and Nivolumab Neoadjuvant to Surgery In Advanced or Recurrent Head and Neck Carcinoma (IMCISION)

First Submitted : December 22, 2016
First Submitted that Met QC Criteria : December 22, 2016
First Posted : December 28, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : February 12, 2021
Last Update Posted : February 15, 2021